BSECompany Update6d ago · 14 Aug 2026, 08:44 am
Appointment of Chief Executive Officer of the Company
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveMgmt Change
Gland Pharma Ltd announced the appointment of Mr. Deepak Sappar as the Chief Executive Officer of the company, effective from November 16, 2022. Mr. Sappar has over 27 years of executive experience, including 23 years in the pharmaceutical industry. He will lead the company's global business expansion, services, API, and product launches across key markets including the US, Europe, Japan, Brazil, China, Mexico, the Middle East, Africa, and Asia.
Analysis Scores
Earnings Impact5/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Management